Smith & Nephew Plc Director/PDMR Shareholding (0601R)

TIDMSN.

RNS Number : 0601R

Smith & Nephew Plc

02 November 2021

SMITH & NEPHEW PLC

2 November 2021

NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ("PDMR") AND PERSONS CLOSELY ASSOCIATED WITH THEM.

 
 Reason for the notification 
 Initial notification        Initial notification 
  /Amendment 
                            ------------------------------------------------ 
 Details of the issuer, emission allowance market participant, 
  auction platform, auctioneer or auction monitor 
 Name                        Smith & Nephew plc 
                            ------------------------------------------------ 
 LEI                         213800ZTMDN8S67S1H61 
                            ------------------------------------------------ 
 Details of the transaction(s): section to be repeated for (i) 
  each type of instrument; (ii) each type of transaction; (iii) 
  each date; and (iv) each place where transactions have been conducted 
 Description of the          Smith & Nephew plc SPON ADR American Depositary 
  financial instrument,       Shares (ADS) 
  type of instrument 
                            ------------------------------------------------ 
 Identification code         ISIN: US83175M2052 
                            ------------------------------------------------ 
 Nature of the transaction   PDMR is a participant of the Company's Employee 
                              Stock Purchase Plan, which on 28 October 
                              2021 purchased American Depository Shares 
                              through the Company's Dividend Re-Investment 
                              Plan following the 2021 interim dividend 
                              payment on 27 October 2021. 
                            ------------------------------------------------ 
 Date of Transaction         2021 - 10 - 28 
                            ------------------------------------------------ 
 Place of Transaction        New York Stock Exchange 
                            ------------------------------------------------ 
 
 
                                                                                   Total Ordinary 
                                                                                    Share Holding 
                                                                Total Ordinary      as a % of 
                                                                 Share Holding      the Company's 
                                                                 following          ISC following 
 Name           Director    Price                Aggregated      the transaction    the transaction 
  (Position)     / PDMR      ($)      Volume      information    *                  * 
 Bradley 
  Cannon 
  (President                                                    77,960.31288 
  Sports                                                         (including 
  Medicine                                       N/A Single      2,433.57588 
  & ENT)        PDMR        35.4472   18.93718    Transaction    in ADS')          0.00881% 
               ----------  --------  ---------  -------------  -----------------  ----------------- 
 Catheryn 
  O'Rourke 
  ( Chief                                                       83,336.93262 
  Legal &                                                        (including 
  Compliance                                     N/A Single      6,218.71164 
  Officer)      PDMR        35.4472   48.39169    Transaction    in ADS')          0.00941% 
               ----------  --------  ---------  -------------  -----------------  ----------------- 
 

* including those held by Persons Closely Associated with the Director/PDMR. All figures in these columns are stated to 5 decimal places where applicable.

Susan Swabey

Company Secretary

Smith & Nephew plc

Tel: [phone]

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHFIFEALELFIIL

(END) Dow Jones Newswires

November 02, 2021 06:29 ET (10:29 GMT)